Author

P. Shinde

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Evolutionary Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:chromatin & epigenetic regulation· 2 Assay:proteomics· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1

Frequent Co-Authors

A. D. Augustine· 1 shared A. Hoch· 1 shared A. Konstorum· 1 shared A. Ozonoff· 1 shared B. Pulendran· 1 shared C. B. Cairns· 1 shared C. Keddy· 1 shared C. Kordes· 1 shared

Activity by Year

2016-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. D. Augustine

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participants

J. P. Gygi, C. Maguire, R. K. Patel, P. Shinde, A. Konstorum, C. P. Shannon, L. Xu, A. Hoch, N. Jayavelu, IMPACC Network, E. K. Haddad, E. F. Reed, M. Kraft, G. A. McComsey, J. Metcalf, , Pete

This study identifies immune programs linked to COVID-19 severity and mortality through longitudinal multi-omics analysis of 1,152 hospitalized patients.

bioRxiv · Nov 3, 2023Immunology

Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors

S. R. Iyer, K. Nusser, K. Jones, P. Shinde, C. Z. Beach, C. Keddy, E. Aguero, J. Force, U. Shinde, M. A. Davare

The paper identifies oncogenic ROS1 missense mutations that are sensitive to tyrosine kinase inhibitors, showing their potential as therapeutic targets.

EMBO Molecular Medicine · Oct 11, 2023Peer-reviewedCancer Biology

Differential modulation of miR-122 transcription by TGFbeta1/BMP6: implications for nonresolving inflammation and hepatocarcinogenesis

M. Paluschinski, C. Kordes, M. Vucur, V. Buettner, H. C. Xu, P. Shinde, P. A. Lang, T. Luedde, M. Castoldi

This study identifies miR-122 as a key regulator in inflammation-associated liver cancer, showing its differential modulation by TGFbeta1 and BMP6 and its link to chronic liver disease.

bioRxiv · Jun 30, 2023Cancer Biology

Codon based co-occurrence network motifs in human mitochondria

P. Shinde, C. Sarkar, S. Jalan

The paper analyzes codon position co-occurrence in human mitochondrial DNA to reveal evolutionary patterns and preferences in codon bias across sub-populations.

bioRxiv · Dec 7, 2016Evolutionary Biology